Rejected topics

Submitted Title Rejected Rationale
17/07/2019 Adult GH commissioning and prescribing
Considered a local issue relating to implementation. Variation in uptake may exist but not this is not clear
04/07/2019 Travel advice
Information already available
17/06/2019 Use of potassium permanganate
System advised to wait for publication of forthcoming British Association of Dermatology guidelines
03/05/2019 Insulin passport
Ongoing work such as that from the Diabetes Hothouse will provide lead
27/03/2019 Need for national patient decision aids for common/high risk medicines
To be considered separately as part of national Over Prescribing work
12/03/2019 free style libre
Funding arrangements for local commissioner determination
20/02/2019 Cost Savings through Brand Prescribing – Salmeterol / Fluticasone MDI 05/03/2019
Consistency of inhaler supply is recommended through brand prescribing of inhalers as outlined in existing local policies
31/12/2018 Prescribing by Private Providers (to include online GP services)
Out with remit of RMOC system
21/12/2018 Use of Jorveza for treating active eosinophilic oesophagitis 16/01/2019
NICE TA due October 2019
20/12/2018 rivaroxaban 2.5mg for PAD/CAD
20/11/2018 Formulary application information for biosimilar adalimumab 16/01/2019
Addressed post submission by December 2018 RMOC Biologics Briefing Note
07/11/2018 eflornithine for use in transgender patients
Noted ongoing work on behalf of both Specialised Commissioning and Low Priority Prescribing so not for RMOC
08/10/2018 Medicines and lifestyle choices for vegetarians and vegans 07/11/2018
Resubmission invited to develop role shared decision making in broader lifestyle choices
20/08/2018 Infliximab for ipilimumab-associated colitis in adults 07/11/2018
Referred to MO CRG for consideration
08/08/2018 Guidance on the appropriate use of anticoagulant reversal agents
Now part of NICE TA programme
01/08/2018 Paravit- CF Liquid and capsule review 05/09/2018
Referred to Specialised Respiratory CRG
05/07/2018 National Extravasation Guideline 05/09/2018
Referred to Cancer CRG
25/06/2018 NICE antimicrobial guidance and PHE ‘Managing common infections in primary care’ 05/09/2018
National guidance now available
20/06/2018 Antibiotics for small intestinal bowel overgrowth (SIBO) 05/09/2018
Referred onward to national AMR team
14/06/2018 Adjuvant bisphosphonates for post-menopausal women with breast cancer to reduce mortality 05/09/2018
NICE Guideline 10 published
14/06/2018 Recomended Prescribing Intervals in Primary Care 11/07/2018
14/05/2018 Actipatch
this item has been rejected
17/04/2018 Prescribing of insulin in frail and elderly who are being managed at home
Topic not progressed on advice of National Clinical Director for diabetes - await GP QOF targets. It is anticipated that many of the issues highlighted by this topic submission will be resolved with the QOF.
16/04/2018 Repeat Prescription management and duration of prescriptions 11/07/2018
14/03/2018 What would a common respiratory prescribing policy look like?
14/03/2018 Diabetes Prescribing
08/03/2018 Out of Pocket Expenses
Out with the remit of RMOC system
20/02/2018 Addressing unwarranted variation in the provision of anticoagulation alert cards to anticoagulation patients
20/02/2018 Hypertension referral pathway for West Midlands
16/02/2018 APCs and Equality Impact Assessments 24/05/2018
Covered by refreshed RMOC Operating Model
09/02/2018 No Cheaper Stock Available
05/02/2018 Bevacizumab (Avastin) for AMD 23/03/2018
02/02/2018 RMOC to review the potential benefits of having appropriate quality assurance support (staff / systems / processes) in place to support the timely and rapid uptake of biosimilars (such as adalimumab) and make appropriate recommendations to commissioners and providers.
30/01/2018 Consistent advice about which flu vaccine to use for which patient group
24/01/2018 Repeat prescribing of Cinacalcet (Mimpara®) in primary care in indication complex primary hyperparathyroidism in adults
19/01/2018 Can CCGs find a way of avoiding VAT On insulin pumps?
16/01/2018 High Cost drugs (pbr excluded) and commissioning pathways for CCGs
Not for RMOC at this stage
16/01/2018 Prescribing of foods for metabolic disease